Although generation of ROI as an effector mechanism during drug-induced apoptosis in cancer cells is well known [39], our results are of interest as they suggest a link between TRAIL sensitization by GSK-3 inhibition and the mitochondrial respiratory chain. The gene discussed is TNFSF10; the disease is cancer.